Dank Research Launches 'Dank Blue Book: Biweekly Top 10 Digital Health News (20160718)'
VCBeat Launches a New Product—Danke Research Institute Blue Book. Curating the most valuable insights in the digital health sector to help you quickly grasp industry dynamics. Below are the must-read highlights for this issue; for more details, please refer to the access instructions at the end of this article.
Startup Health: Global Digital Health Investment and Financing Report for the First Half of 2016
According to Startup Health’s mid-2016 report, total investment and financing in the digital health sector reached a record high of $3.9 billion in the first half of 2016. The number of seed-stage and Series A financing rounds was roughly equal, reflecting a thriving landscape for early-stage tech innovators. Moreover, the majority of capital was injected at the Series A stage, providing greater opportunities for startups.
Keywords: Digital Health, Financing
VCBeat: Report on Digital Health Investment and Financing in China in the First Half of 2016
As of June 30, 2016, VCBeat Research Institute compiled and released the Q2 2016 China Digital Health Market Investment and Financing Report, based on publicly available data on digital health investments and financing in China. In the second quarter of 2016, there were a total of 60 investment and financing transactions, with the total funding amount reaching $977.73 million, representing an 83.1% quarter-on-quarter increase.
Keywords: Digital Health, Internet Healthcare, Financing
MOHRSS Issues Guiding Opinions on Promoting the “Three-Medical Linkage” Reform
To thoroughly implement the series of decisions and arrangements made by the CPC Central Committee and the State Council on the reform of the medical and healthcare system, and to carry out2016Key Tasks for Annual Healthcare Reform: Strengthening the Coordination of Medical Services, Health Insurance, and Pharmaceutical Sectors; Further Clarifying the Role and Responsibilities of Human Resources and Social Security Departments in Healthcare Reform. The Ministry of Human Resources and Social Security issued the “Guiding Opinions on Actively Promoting the Linked Reform of Medical Services, Health Insurance, and Pharmaceuticals” (hereinafter referred to as the “Opinions”), deploying arrangements for human resources and social security departments to advance the linked reform of the three sectors and effectively carry out healthcare reform-related work.
Keywords: Medical Insurance, Pharmaceuticals
Wanjia Medical Officially Established Ping An of China Builds Offline Chain Health Service Platform
Wanjia Medical envisions itself as “China’s Leading Platform for Chain Health Services,” focusing its business on the integration, standardization, and enhancement of offline primary healthcare resources, represented by clinics, and plans to2016Within the year, tens of thousands of various private medical institutions were onboarded onto the Wanjia Platform. Currently, Wanjia Medical has already collaborated with the Joint Commission International (JCI) and DNV GL The medical groups have entered into a strategic partnership to jointly develop and release a certification standard system for Chinese primary healthcare institutions, based on international standards. The certification and assessment process will be initially implemented among online clinics to comprehensively enhance their medical service quality and operational management capabilities.
Keywords: Finance & Insurance, Health & Medical Pharmaceuticals
NDRC Issues Document to Advance Reform of Medical Service Pricing
Recently, with the approval of the State Council, the National Development and Reform Commission, in conjunction with the National Health and Family Planning Commission, the Ministry of Human Resources and Social Security, and the Ministry of Finance, issued the “Notice on Printing and Distributing the Opinions on Advancing the Reform of Medical Service Prices.” The notice requires that efforts be closely aligned with the objectives of deepening the reform of the medical and healthcare system, actively and steadily advancing the reform of medical service prices, adhering to a combination of price adjustments and market-based pricing, strengthening policy coordination, and gradually establishing a price formation mechanism characterized by classified management, dynamic adjustment, and multi-party participation.
Keywords: Price Reform, Medical Services, National Development and Reform Commission (NDRC), Policy Standards
Alibaba Health1680Acquisition of Guangzhou Five Thousand Years Pharmaceutical Chain Co., Ltd. for 10,000 Yuan
7Month6On [date], Alibaba Health announced that it had entered into an acquisition agreement with Guangzhou Five Thousand Years Pharmaceutical Chain Co., Ltd. to1680acquire 100% equity interest in the company for a price of RMB 10,000. Regarding Guangzhou Wunian Pharmaceutical Chain Co., Ltd., Alibaba Health stated in its announcement, “The current registered capital of Wunian Pharmaceutical Chain Co., Ltd. is RMB500RMB 10,000. The Target Company is primarily engaged in the retail business of pharmaceuticals and traditional Chinese medicine decoction pieces in China, operates a chain of pharmaceutical retail stores, and holds the Internet Drug Transaction Service Qualification Certificate, which entitles it to sell online over-the-counter drugs and certain other regulated products as listed in the relevant regulations.
Keywords: Ali Health, Guangzhou Wunian Pharmaceutical Chain, pharmaceutical e-commerce, pharmaceuticalsB2C
Medtronic11Billion-dollar M&AHeartWare, deeply engaged in the field of heart failure
Medtronic has officially announced that it hasHeartWareReached a final merger and acquisition agreement; under the agreement, Medtronic will make a tender offer for allHeartWarePayment per share of common stock outstanding58Cash in U.S. dollars. The boards of directors of both companies have currently approved the transaction. This move will enrich Medtronic’s heart failure product portfolio.HeartWareThe company's flagship product isHVADSystem, a very small ventricular assist device (VAD), to reduce surgical trauma, shorten patient recovery time, and improve clinical outcomes.
Keywords: Medtronic, heart failure,HeartWare
State Administration for Industry and Commerce: Medical and Pharmaceutical Advertisements Shall Not Be Published on the Internet Without Prior Review
According to the website of the State Administration for Industry and Commerce, the Administration today announced the Interim Measures for the Administration of Internet Advertising, effective from2016Year9Month1shall come into force as of the date of implementation. The Measures stipulate that advertisements for special commodities or services, such as those for medical treatments, pharmaceuticals, and health foods, which are subject to review by the advertising review authorities, shall not be published without prior review.
Keywords: State Administration for Industry and Commerce, medical and pharmaceutical advertisements
2016Global and Chinese Pharmaceutical Companies' Market Capitalization Landscape in the First Half of the Year
2016In the first half of the year, the global pharmaceutical companies' market capitalization top20What are the strengths, in the Chinese market ahead20Which ones are strong? Compared with the end of last year, there have not been significant changes in the market capitalization rankings of pharmaceutical stocks in the first half of the year; the top spot was taken by a company with a market cap1041Shanghai RAAS, valued at over RMB 10 billion, was acquired from Hengrui Medicine. In the first half of the year, Sinopharm Group ranked second in market capitalization.1022.44Acquired for hundreds of millions of yuan, Sinopharm Group’s market capitalization has skyrocketed in the first half of this year; last year12Month31At the time, the market capitalization was merely720.9100 million yuan,6months, its market capitalization increased by nearly300hundred million yuan. Although Hengrui Medicine currently947.32with revenues in the hundreds of millions of yuan, it ranked third, yet it remains one of the most outstanding enterprises in China’s domestic pharmaceutical industry.
Keywords: Medicine, Pharmaceutical Factory
GoogleDeepMindWith the UKNHSAnnouncing Collaboration to Cure Eye Diseases
DeepMindis aGooglesubsidiary, recently announced a research plan. The plan collaborates with the UK's National Health ServiceMoorfieldsThe hospital uses artificial intelligence technology to screen for and treat blinding eye diseases.
Keywords:Google、DeepMind、NHSArtificial Intelligence
The above are the curated highlights from this issue of the "Little Blue Book." The full edition contains over 70 major news items, covering investment and financing, policies, industry developments, products, technologies, market research, and more that have occurred in the past half month.
To obtain the “Blue Book,” you can use the following two methods:
Click to go to VCBeat.Direct Purchase
Or
Follow the VCBeat WeChat Official Account, share the post on WeChat, and complete the questionnaire.FreeObtain
